心血管

订阅

MedSci主页 / 所有栏目 / 心血管

SCTM：新型干细胞可治疗心力衰竭

2015-08-06 佚名 生物谷

干细胞心力衰竭
关注

近日，一种新的研究方法可传递干细胞到受损心肌细胞从而治疗严重的心脏衰竭，本文于7月27日发表在《干细胞转化医学》杂志上。 Amit Patel医学博士，他是盐湖城犹他大学心血管再生医学主任，他和他的同事们招募了60名严重的心力衰竭患者。他们随机分配48名患者到常规护理干细胞疗法组，另外12名患者只用标准疗法治疗。 研究人员指出，干细胞疗法非常安全，治疗本身没有副作用。一年之后，病人的射血分数有

近日，一种新的研究方法可传递干细胞到受损心肌细胞从而治疗严重的心脏衰竭，本文于7月27日发表在《干细胞转化医学》杂志上。

Amit Patel医学博士，他是盐湖城犹他大学心血管再生医学主任，他和他的同事们招募了60名严重的心力衰竭患者。他们随机分配48名患者到常规护理干细胞疗法组，另外12名患者只用标准疗法治疗。

研究人员指出，干细胞疗法非常安全，治疗本身没有副作用。一年之后，病人的射血分数有了适度改善。目前还不清楚这些改善是否可能有意义，Patel补充说，更大的临床试验正在进行中用来观察这种方法是否可以作为重度心衰的适用方法。

Patel的团队使用了一种新颖的技术可将干细胞传递到心脏。他们从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中。“其他技术是通过动脉注入干细胞，”Patel解释道，心力衰竭患者普遍都有的一个障碍是硬化现象，它缩小了冠状动脉，注入的干细胞“不应该经常去这个地方。

原文出处：

Amit N. Patela, Sanjay Mittalb, Goekmen Turan et al.REVIVE Trial: Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure.Stem Cells Translatonal Medicine.July 27, 2015

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=47577, encodeId=43594e57776, content=从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Thu Dec 24 21:09:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35301, encodeId=ba0335301d5, content=这么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35302, encodeId=23923530272, content=期待临床试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35303, encodeId=472335303f2, content=继续更近, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35036, encodeId=8a763503644, content=对目前心血管的研究提供了极大帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 22:38:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-12-24 inter158

    从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=47577, encodeId=43594e57776, content=从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Thu Dec 24 21:09:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35301, encodeId=ba0335301d5, content=这么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35302, encodeId=23923530272, content=期待临床试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35303, encodeId=472335303f2, content=继续更近, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35036, encodeId=8a763503644, content=对目前心血管的研究提供了极大帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 22:38:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-08-08 Messichen1992

    这么厉害

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=47577, encodeId=43594e57776, content=从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Thu Dec 24 21:09:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35301, encodeId=ba0335301d5, content=这么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35302, encodeId=23923530272, content=期待临床试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35303, encodeId=472335303f2, content=继续更近, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35036, encodeId=8a763503644, content=对目前心血管的研究提供了极大帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 22:38:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-08-08 Messichen1992

    期待临床试验

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=47577, encodeId=43594e57776, content=从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Thu Dec 24 21:09:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35301, encodeId=ba0335301d5, content=这么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35302, encodeId=23923530272, content=期待临床试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35303, encodeId=472335303f2, content=继续更近, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35036, encodeId=8a763503644, content=对目前心血管的研究提供了极大帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 22:38:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-08-08 Messichen1992

    继续更近

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=47577, encodeId=43594e57776, content=从患者的骨髓中抽取干细胞并通过冠状窦注入到心脏中, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151226/IMG567EB873985DE3928.jpg, createdBy=ea941622301, createdName=inter158, createdTime=Thu Dec 24 21:09:00 CST 2015, time=2015-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35301, encodeId=ba0335301d5, content=这么厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35302, encodeId=23923530272, content=期待临床试验, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35303, encodeId=472335303f2, content=继续更近, beContent=null, objectType=article, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ed101627734, createdName=Messichen1992, createdTime=Sat Aug 08 19:12:00 CST 2015, time=2015-08-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=35036, encodeId=8a763503644, content=对目前心血管的研究提供了极大帮助, beContent=null, objectType=article, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=332823945, createdName=hlycom3356, createdTime=Thu Aug 06 22:38:00 CST 2015, time=2015-08-06, status=1, ipAttribution=)]
    2015-08-06 hlycom3356

    对目前心血管的研究提供了极大帮助

    0

相关资讯

药物研发史上里程碑式的进展——科学家可无限制的生产功能性肝细胞

肝脏在人体代谢过程中起着重要的作用。作为消化道的“门卫”，肝脏负责药物的降解，因此成为了最易由于药物过量或滥用而受损的器官。评估药物诱导性肝损伤是研发药物的重要部分，必须对人体干细胞进行研究实验。遗憾的是，人类干细胞的供应很少，仅能从捐赠的器官中分离获得。现在，发表于《肝脏病学杂志 》的一项研究表明，科学家已成功通过人胚胎干细胞和基因功能诱导出大量有功能的肝细胞。“这是药物研发史上一个革

Science重大成果：神奇的再生药丸

服下一片药丸，新组织就会突然长出来替换受损的组织，这一想法听起来有点像是科幻小说。来自凯斯西储大学和德克萨斯大学西南医学中心的研究人员本周宣布，他们在将这一曾经看似不可能的想法变为鲜活现实的道路上迈出了重要的步伐。在发表于6月12日《科学》（Science）杂志上的一项新研究中，他们描述了一种新药如何修复了动物模型中的结肠、肝脏和骨髓损伤——甚至挽救了骨髓移植模型中本来会死掉的小鼠的生命。凯斯

诱导干细胞进入全能时代

                                     现在科学家们已经可以在体外利用各种类型细胞进行多能干细胞的诱导，来自德国的科学家又将这一技术推进一步，他们在发表在国际学术期刊

干细胞治疗下肢血管病变的临床试验开展和相关进展

在2014（第六届）干细胞技术临床应用论坛上，黄平平教授为我们做了精彩分享，演讲主题为：干细胞治疗下肢血管病变的临床试验开展和相关进展。 黄平平，博士、教授、北京协和医学院硕士和博士研究生导师，中国医学科学院血液病医院主任医师。中华医学会医学工程学会干细胞工程专业委员会委员。黄教授的演讲视频已上传至行云学院供交流学习。 随着生活水平的提高及人口老龄化，糖尿病等引起的下肢血管病变在我国的发病

NCB：快速高效获得血管细胞新方案

                                                      多能干细胞(Pl

Stem Cells：经IL-17处理的干细胞可能控制移植病人的排斥反应

    这篇刊登在国际期刊Stem Cells上的研究有望为移植病人引导出新的治疗方法。阿得雷德大学药学院以及皇家阿德莱医院肾移植单位博士研究生Kisha Sivanathan说道，这项研究在干细胞领域是一项令人激动的突破。    “成人骨髓间充质干细胞，一种可以从人体许多组织包括骨髓中提取获得的细胞，该种细胞由于其治疗特性并且易于培养，一直吸引着